Complement and its fractions (C₃-C₄) pattern in subjects with neoplasiaMANGANO, A; MESSINA, L; BIRGILLITO, S et al.Journal of immunopharmacology. 1984, Vol 6, Num 3, pp 147-162, issn 0163-0571Article

Conditions for the generation of high serum levels of C3DP = Conditions favorables à la production de taux élevés sériques de C3DPWHITE, P. J; HOCH, S. O.Cancer biochemistry biophysics. 1982, Vol 6, Num 1, pp 19-22, issn 0305-7232Article

DEMONSTRATION OF IMMUNOGLOBULIN IN TUMOR AND MARGINAL TISSUES OF SQUAMOUS CELL CARCINOMAS OF THE HEAD AND NECK.KONEVAL T; APPLEBAUM E; POPOVIC D et al.1977; J. NATION. CANCER INST.; U.S.A.; DA. 1977; VOL. 59; NO 4; PP. 1089-1097; BIBL. 14 REF.Article

CHARACTERIZATION OF HEAT ELUATES OF HUMAN MALIGNANT TISSUESWESENBERG F.1979; ACTA PATHOL. MICROBIOL. SCAND., C; DNK; DA. 1979; VOL. 87; NO 4; PP. 301-306; BIBL. 15 REF.Article

Human monocyte recognition of complement-coated lymphoblastoid cellsARMSTRONG, S; MCDERMOTT, P; SCHREIBER, A. D et al.Journal of leukocyte biology. 1985, Vol 37, Num 2, pp 161-174, issn 0741-5400Article

Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3aKRETZCHMAR, T; JEROMIN, A; GIETZ, C et al.European journal of immunology. 1993, Vol 23, Num 2, pp 558-561, issn 0014-2980Article

C3 production of cultured human epidermal keratinocytes is enhanced by IFNγ and TNFα through different pathwaysTERUI, T; ISHII, K; OZAWA, M et al.Journal of investigative dermatology. 1997, Vol 108, Num 1, pp 62-67, issn 0022-202XArticle

Natural Killer-22 Cells in the Synovial Fluid of Patients with Rheumatoid Arthritis Are an Innate Source of Interleukin 22 and Tumor Necrosis Factor-αJIE REN; ZHITAO FENG; ZHUO LV et al.Journal of rheumatology. 2011, Vol 38, Num 10, pp 2112-2118, issn 0315-162X, 7 p.Article

Dual effects of TNF on synthesis of Complement components by a gastric cancer-derived cell line, KATO-IIIKITANO, E; KITAMURA, H.International archives of allergy and immunology. 1999, Vol 119, Num 1, pp 54-59, issn 1018-2438Article

Synthesis of the third component of complement (C3) by human gastric cancer-derived cell linesKITANO, E; KITAMURA, H.Clinical and experimental immunology (Print). 1993, Vol 94, Num 2, pp 273-278, issn 0009-9104Article

Il-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblastsKATZ, Y; STAV, D; BARR, J et al.Clinical and experimental immunology (Print). 1995, Vol 101, Num 1, pp 150-156, issn 0009-9104Article

Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cellsCURD, L. M; FAVORS, S. E; GREGG, R. K et al.Clinical and experimental immunology (Print). 2012, Vol 168, Num 2, pp 192-199, issn 0009-9104, 8 p.Article

Plasma therapy of primary rat mammary carcinoma: dependence of consumption of C3 during absorption of plasma with Sepharose derivatives on the anticoagulantNAKANISHI, K; ZBAR, B; BORSOS, T et al.Cancer research (Baltimore). 1985, Vol 45, Num 9, pp 4122-4127, issn 0008-5472Article

Defective expression of basement membrane-associated C3d,g in papulonodular basal cell carcinomasBASSET-SEGUIN, N; UHLE, P; EMANUEL, D et al.Journal of investigative dermatology. 1989, Vol 92, Num 5, pp 734-738, issn 0022-202XArticle

THE SPONTANEOUS RELEASE OF A HIGH-MOLECULAR-WEIGHT AGGREGATE CONTAINING IMMUNOGLOBULIN G FROM THE SURFACE OF EHRLICH ASCITES TUMOR CELLSRITTENHOUSE HG; AR D; LYNN MD et al.1978; J. SUPRAMOLEC. STRUCT.; USA; DA. 1978; VOL. 9; NO 3; PP. 407-419; BIBL. 24 REF.Article

Interleukin-1 and tumor necrosis factor-mediated regulation of C3 gene expression in human astroglioma cellsBARNUM, S. R; JONES, J. L; BENVENISTE, E. N et al.Glia (New York, NY. Print). 1993, Vol 7, Num 3, pp 225-236, issn 0894-1491Article

Photodynamic therapy-generated vaccine for cancer therapyKORBELIK, Mladen; JINGHAI SUN.Cancer immunology and immunotherapy. 2006, Vol 55, Num 8, pp 900-909, issn 0340-7004, 10 p.Article

HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanomaZUBOVITS, Judit; BUZNEY, Elizabeth; YU, Lawrence et al.Human pathology. 2004, Vol 35, Num 2, pp 217-223, issn 0046-8177, 7 p.Article

Increased intratumoral IL-22-producing CD4⁺ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survivalYUAN ZHUANG; PENG, Liu-Sheng; PING LUO et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 11, pp 1965-1975, issn 0340-7004, 11 p.Article

Differential modulation of complement factor H and C3 expression by TNF-α in the rat. In vitro and in vivo studiesJULEN, N; DAVRINCHE, C; OZANNE, D et al.Molecular immunology. 1992, Vol 29, Num 7-8, pp 983-988, issn 0161-5890Article

The endothelium is an extrahepatic site of synthesis of the seventh component of the complement systemLANGEGGEN, H; PAUSA, M; JOHNSON, E et al.Clinical and experimental immunology (Print). 2000, Vol 121, Num 1, pp 69-76, issn 0009-9104Article

Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytesBOTTO, M; LISSANDRINI, D; SORIO, C et al.The Journal of immunology (1950). 1992, Vol 149, Num 4, pp 1348-1355, issn 0022-1767Article

Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomasANDOH, A; FUJIYAMA, Y; SAKUMOTO, H et al.Clinical and experimental immunology (Print). 1998, Vol 111, Num 3, pp 477-483, issn 0009-9104Article

Modulation of C2 and C3 gene expression of human peripheral blood monocytes by interleukin 1β, interferon γ, tumor necrosis factor α and lipopolysaccharideSHIMIZU, H; SAKANO, T; FUJIE, A et al.Experientia. 1992, Vol 48, Num 11-12, pp 1148-1150, issn 0014-4754Article

The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophagesBARA, S; LINT, T. F.The Journal of immunology (1950). 1987, Vol 138, Num 4, pp 1303-1309, issn 0022-1767Article